Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
A2585 MG-132125 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A4393 Paclitaxel (Taxol)28 CitationTarget: Microtubules/TubulinsSummary: microtubule depolymerization inhibitor -
A4002 IU11 CitationSummary: Usp14 inhibitor -
A2571 Pepstatin A9 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: aspartic proteases inhibitor -
A3966 Doxorubicin36 CitationSummary: DNA topoisomerase II inhibitor -
A2614 Bortezomib (PS-341)52 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A8487 Nocodazole8 CitationTarget: Microtubules/TubulinsSummary: microtubule polymerization inhibitor -
A8198 P 22077Summary: USP7/(DUB)USP47 inhibitor -
A3023 P0050911 CitationTarget: Ubiquitin-specific proteasesSummary: Ubiquitin-specific protease 7 (USP7) inhibitor -
A4003 LDN 57444Target: UCHSummary: UCH-L1 inhibitor,reversible competitve

